Why the study?
Among patients with carotid artery stent placement and AF, triple therapy confers a high bleeding risk, warranting evaluation of direct oral anticoagulants plus a P2Y12 inhibitor.
Does a regimen of direct oral anticoagulants plus a P2Y12 inhibitor reduce bleeding compared to triple therapy in patients with carotid artery stent placement and atrial fibrillation?
Does a regimen of direct oral anticoagulants plus a P2Y12 inhibitor reduce bleeding compared to triple therapy in patients with carotid artery stent placement and atrial fibrillation?
Dual therapy with a DOAC and P2Y12 inhibitor may offer a safer alternative to triple therapy for patients with atrial fibrillation undergoing carotid stenting.
Answers are grounded in this paper and cite their sources.
May support dual DOAC-P2Y12 over triple therapy post-carotid stenting in AF; leaves open confirmation by RCTs.
Among patients with carotid artery stent placement with atrial fibrillation, triple therapy confers a high bleeding risk. A regimen of direct oral anticoagulants plus a P2Y12 inhibitor might confer a good safety profile with significantly lower rates of bleeding and optimal efficacy.
No takes yet. Share an insight, caveat, or question.
Pardo-Galiana et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: